Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Clinical Trial ID NCT00666588

PubWeight™ 6.89^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00666588

Top papers